Imtech: 130 million euro orders for innovation in the German care & cure market
Gouda - Imtech N.V. (technical services provider in Europe) announces that it has been awarded orders worth over 130 million euro in the care & cure sector in Germany. Innovation is the key word here. Imtech is involved in various innovations relating to ventilation, energy efficiency, ultra clean air in operating theatres and the use of medical gases.
René van der Bruggen, CEO Imtech: 'Technology in the care & cure market is becoming increasingly important. As demand for health care rises, integration of technological solutions and innovation are making better care possible. At the same time, integration and innovation contribute to lower operating costs, a considerable increase in energy efficiency and a reduction in harmful emissions. Specific technology makes it easier to comply with new norms for hygiene, safety and (patient) welfare. The German care & cure market is an important growth market for Imtech.'
Technological innovation in care & cure
In Germany, Imtech is increasingly active for a large number of hospitals, health centres, medical clinics and research institutes. The focus is on growth. The care & cure market increasingly requires specific technology which complies with new norms for hygiene, safety and (patient) welfare in combination with high energy efficiency. More and more, Imtech acts as an expert technology partner. Besides providing complete technical infrastructure solutions (through the combination of electrical services, ICT - information and communications technology - and mechanical services), Imtech focuses strongly on technological innovation. Imtech innovations increasingly find their way to the market. An important innovation is the use of a new type of ventilation system in hospital wards. In contrast to conventional approaches, new Imtech technology is used to create the best combination of functionality for the patients, welfare for doctors and nurses and high energy efficiency with minimizing CO2 for the environment. An innovative concept has also been developed for ultra clean air in operating theatres, which prevents post-operative infectious complications. Other examples are complex technology solutions for the use of medical gases (oxygen, nitrogen, laughing gas, etc.), innovative (emergency) paging systems for patients and medical personnel, energy efficient power supplies and smart emergency power facilities.
High volume of recent orders
Imtech has recently been involved in several innovative technical processes and projects in numerous medical clinics, (university) hospitals and health centres in for instance the Rems Murr clinic in Winnenden, the Schwarzwald Baar clinic in Villingen-Schwenningen, the academic hospital of the University of Tübingen, the academic hospital of the University of Ulm, the St. Josefs hospital in Freiburg and Heidelberg, the clinic of Stuttgart Mitte (Stuttgart Center) and several other smaller hospitals and (health) clinics. For the Max-Planck-Institute für Eisenforschung (MPIE) in Düsseldorf, a leading institute in medical research, Imtech is equipping a high quality research centre to improve the health of the elderly. Further growth in the German care & cure market is expected.
0-0-0-0-0-0-0-0-0-0
More information
| Media: | Analysts & investors: |
| Pieter Koenders Director Corporate Communications T: +31 655 74 65 85 E: pieter.koenders@imtech.eu www.imtech.eu | Jeroen Leenaers Manager Investor Relations T: +31 182 54 35 04 E: jeroen.leenaers@imtech.eu www.imtech.eu |
Imtech profile
Imtech N.V. is a European technical services provider in the fields of electrical services, ICT (information and communication technology) and mechanical services. With over 26,000 employees, Imtech achieves annual revenue of around 4.5 billion euro. Imtech holds strong positions in the buildings and industry markets in the Netherlands, Belgium, Luxembourg, Germany, Austria, Eastern Europe, Sweden, Norway, Finland, the UK, Ireland and Spain, the European markets of ICT and Traffic as well as in the global marine market. In total Imtech serves 21,000 customers. Imtech offers added value with integrated and multidisciplinary total solutions that lead to better business processes and more efficiency for customers and the customers they, in their turn, serve. Imtech also offers solutions that contribute towards a sustainable society, for example green tech solutions and solutions in the areas of energy, the environment, water and mobility. Imtech shares are listed on NYSE Euronext in Amsterdam, where Imtech is included in the Midkap Index. Imtech shares are also included in the Dow Jones STOXX 600 index.
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Imtech N.V. via Thomson Reuters ONE
HUG#1498383
-
Most popular related searches
Related news
-
Artugen Announces Five Abstracts Published in the 30th ECCMID Abstract Book
Clostridioides difficile infection (CDI) causes the most common healthcare-associated infections in the United States and the most frequent hospital-acquired intestinal infection in Europe and worldwide. The prevalence of C. difficile outbreaks since the early 2000s has resulted in higher morbidity and mortality along with increasing medical costs throughout the world. Without effective antibiotics and therapeutics for the prevention and treatment of infections, many of the achievements of modern medicine such...
-
Professional Old Age Home Care Services in Australia
JK Home Care is delighted to extend its range of professional home care services in Australia. Transforming home care solutions, the specialized team of qualified experts at JK Home Care offer world-class therapeutic supports, specialized supported employment, specialized positive behavior support, participation in the community, innovative community participation, home modifications and more aligned to the patient’s requirement. JK Home Care was born out of a desire to care and give back to the community....
-
Diaphragm Pacemaker for Teen Featured on WSB-TV Atlanta
Fourteen year-old Sedarius was recently featured on WSB-TV Atlanta as the first pediatric patient to receive surgery to implant a diaphragm pacemaker in the state of Georgia. Sedarius was diagnosed with CCHS when he was eight years old, and required a tracheotomy and ventilator to breathe while he slept. The Avery Breathing Pacemaker will allow him to breathe without the need for a trach or ventilator and help improve his quality of life. He was able to return home within a few days, and it is expected that he...
-
Flat Medical announced FDA 510(k) clearance of EpiFaith, the Epidural Safety Solution
Flat Medical Co., Ltd., the medtech company specializing in clinical safety solutions, announced it received 510(k) clearance from the U.S. Food and Drug Administration for its EpiFaith® syringe to deliver safe epidural locating solution. Based on the LOR technique, the EpiFaith® syringe is a physician-centered safeguard for epidural analgesia, which is indicated for painless labor, surgical anesthesia and chronic pain management. Compared with traditional practice that relies on the manual sense, EpiFaith&...
-
Haymarket Medical Network Launches Rare Disease Advisor
Haymarket Medical Network today launched Rare Disease Advisor, a new digital resource for healthcare professionals (HCPs) to help them recognize, diagnose, refer and treat rare diseases. RareDiseaseAdvisor.com fills an information gap for HCPs by providing difficult to find information on rare diseases in one convenient place, enabling physicians and care teams with a comprehensive digital resource that will empower them to improve patient outcomes. The site’s thorough approach to covering rare disease...
Customer comments
No comments were found for Imtech: 130 million euro orders for innovation in the German care & cure market. Be the first to comment!